[ZVRA] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[ZVRA] Zevra Therapeutics, Inc.
Announcement Date
29-Sep-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -176.26%
YoY- -112.29%
Quarter Report
ZVRA's Result
ZVRA's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 4,449 3,425 13,217 2,895 8,470 2,879 2,319 54.45%
PBT -19,855 -16,692 -15,153 -13,868 -5,158 -11,870 -9,055 68.86%
Tax 70 -70 0 177 -74 -103 -34 -
NP -19,925 -16,622 -15,153 -14,045 -5,084 -11,767 -9,021 69.68%
Tax Rate - - - - - - - -
Total Cost 24,374 20,047 28,370 16,940 13,554 14,646 11,340 66.62%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -447.85 -485.31 -114.65 -485.15 -60.02 -408.72 -389.00 9.85%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.48 -0.40 -0.40 -0.40 -0.15 -0.34 -0.26 50.54%
EPS Diluted -0.48 -0.40 -0.40 -0.40 -0.15 -0.34 -0.26 50.54%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.